MRS to Determine Neuroinflammation and Oxidative Stress in MPS I

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Mucopolysaccharidosis Type I
Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

Rare Diseases Clinical Research Network

NETWORK

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Lysosomal Disease Network

OTHER

lead

University of Minnesota

OTHER

NCT03576729 - MRS to Determine Neuroinflammation and Oxidative Stress in MPS I | Biotech Hunter | Biotech Hunter